Reduced varicella-zoster-virus (VZV)-specific lymphocytes and IgG antibody avidity in solid organ transplant recipients
- 1 May 2013
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 31 (20), 2420-2426
- https://doi.org/10.1016/j.vaccine.2013.03.058
Abstract
No abstract availableFunding Information
- Austrian Jubilaeumsfonds
This publication has 52 references indexed in Scilit:
- Serologic Analysis of the IgG Antibody Response in Children With Varicella Zoster Virus Wild-type Infection and VaccinationThe Pediatric Infectious Disease Journal, 2012
- Evaluation of Three Commercial Varicella-Zoster Virus IgG Enzyme-Linked Immunosorbent Assays in Comparison to the Fluorescent-Antibody-to-Membrane-Antigen TestClinical and Vaccine Immunology, 2012
- Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workersJournal of Clinical Virology, 2012
- Follow-up of pregnant women exposed to chicken pox: an audit of relationship between level of antibody and development of chicken poxEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Aciclovir and Varicella-zoster-immunoglobulin in solid-organ transplant recipientsPediatric Nephrology, 2010
- Varicella vaccination in pediatric kidney and liver transplantationPediatric Transplantation, 2010
- VaricellaThe Lancet, 2006
- Serological Detection of Varicella-Zoster Virus-Specific Immunoglobulin G by an Enzyme-Linked Immunosorbent Assay Using Glycoprotein AntigenJournal of Clinical Microbiology, 2006
- Antibody Avidity as a Surrogate Marker of Successful Priming byHaemophilus influenzaeType b Conjugate Vaccines following Infant ImmunizationThe Journal of Infectious Diseases, 1998
- ASSAYS FOR ANTIBODIES TO VARICELLA-ZOSTER VIRUSInfectious Disease Clinics of North America, 1996